We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02097810
Brief Title: Study of Oral RXDX-101 in Adult Patients With Locally Advanced or Metastatic Cancer Targeting NTRK1, NTRK2, NTRK3, ROS1, or ALK Molecular Alterations. (STARTRK-1)

First Submitted : March 21, 2014
First Submitted that Met QC Criteria : March 24, 2014
First Posted : March 27, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : June 7, 2021
Last Update Posted : June 9, 2021